Perrigo Sues FDA For Failing To Publish Approval Of Gel

Law360, Washington (March 24, 2014, 2:20 PM EDT) -- Perrigo Israel Pharmaceuticals Ltd. on Friday sued the U.S. Food and Drug Administration in D.C. federal court, alleging the agency has failed to update its records to reflect its approval of Perrigo's testosterone gel product.

The company sued to redress the agency's alleged failure to timely update its so-called Approved Drug Products with Therapeutic Equivalence Evaluations — also known as the Orange Book — to add a therapeutic equivalence rating for the testosterone gel, which is a generic version of AbbVie's AndroGel.

The alleged failure "continues...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.